Management of adrenal insufficiency risk after long-term systemic glucocorticoid therapy in Duchenne muscular dystrophy: Clinical practice recommendations

Authors

Sasigarn A. Bowden, The Ohio State University
Anne M. Connolly, Washington University School of Medicine in St. Louis
Kathi Kinnett, Parent Project Muscular Dystophy, Hackensack
Philip S. Zeitler, University of Colorado

Journal

Journal of Neuromuscular Diseases

Publication Date

2019

Volume

6

Issue

1

First Page

31

Last Page

41

Document Type

Open Access Publication

DOI

10.3233/JND-180346

Rights and Permissions

Bowden SA, Connolly AM, Kinnett K, Zeitler PS. Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations. J Neuromuscul Dis. 2019;6(1):31-41. doi: 10.3233/JND-180346. © 2019 – IOS Press and the authors. All rights reserved This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC 4.0).

Recommended Citation

Bowden, Sasigarn A.; Connolly, Anne M.; Kinnett, Kathi; and Zeitler, Philip S., "Management of adrenal insufficiency risk after long-term systemic glucocorticoid therapy in Duchenne muscular dystrophy: Clinical practice recommendations." Journal of Neuromuscular Diseases. 6, 1. 31 - 41. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/9125